Pricing Log in Create free account

Anbio Biotechnology (NNNN) vs STAAR Surgical Company (STAA)

Anbio Biotechnology and STAAR Surgical Company are both Medical Instruments & Supplies companies. STAAR Surgical Company is the larger, with a market value of $1.3B against $516.6M — 2.6× the size. Across the 8 metrics below, STAAR Surgical Company leads on 5 and Anbio Biotechnology on 3.

Valuation

Metric NNNN STAA Medical Instruments & Supplies median
P/E — n/m 30.28
P/S — 4.08 2.49
P/B n/m 3.56 2.34
Price to free cash flow n/m 75.31 23.49
EV/EBITDA n/m 50.15 14.87
EV/Sales n/m 3.54 2.75
Earnings yield — 0.00% 0.00%
Free cash flow yield 0.00% 1.33% 0.59%

Profitability

Metric NNNN STAA Medical Instruments & Supplies median
Gross margin — 73.56% 53.60%
Operating margin — 0.21% 1.97%
Net margin — 0.16% 0.00%
Free cash flow margin 0.00% 5.44% 2.36%
Return on equity 0.00% 0.15% 0.00%
Return on assets 0.00% 0.11% 0.00%
Return on invested capital 0.00% 0.26% 0.13%

Growth

Metric NNNN STAA Medical Instruments & Supplies median
Revenue growth (TTM) — 42.36% 8.97%
EPS growth (last fiscal year) 150.00% (295.12%) 6.51%
Revenue growth, 5-year CAGR — 7.93% 8.85%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NNNN STAA Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 344.45 4.68 2.47
Net debt to EBITDA (2.06) 2.25 0.97

Dividend

Metric NNNN STAA Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric NNNN STAA Medical Instruments & Supplies median
Market cap 516.57m 1.34b 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack